Package 0338-9667-01

Brand: doxil

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0338-9667-01
Digits Only 0338966701
Product NDC 0338-9667
Product ID 0338-9667_bfc1b628-0b1c-4262-b80b-7e5505c8f112
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9667-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-08-26
Brand doxil
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

DOXIL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "bfc1b628-0b1c-4262-b80b-7e5505c8f112", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127", "1790128", "1790131"], "spl_set_id": ["917eddf9-1d3f-4abe-8c81-d33b066e5bae"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9667-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0338-9667-01", "marketing_start_date": "20240826"}], "brand_name": "DOXIL", "product_id": "0338-9667_bfc1b628-0b1c-4262-b80b-7e5505c8f112", "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0338-9667", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOXIL", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "NDA050718", "marketing_category": "NDA", "marketing_start_date": "20240826", "listing_expiration_date": "20271231"}